AstraZeneca PLC
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| AZN.ST | 4503.T | MRK | LLY | PFE | NVS | |
|---|---|---|---|---|---|---|
| Market cap | 2.58T | 4.45T | 365.88B | 1.14T | 171.62B | 292.03B |
| P/E (TTM) | 26.6 | 12.2 | 117.7 | 43.1 | 39.6 | 23.2 |
| Forward P/E | — | 32.7 | 16.0 | 27.2 | 10.4 | 15.7 |
| Price/book | 51.4 | 2.3 | 8.7 | 33.8 | 2.0 | 7.0 |
| Dividend yield | 1.85% | 3.29% | 2.29% | 0.54% | 5.71% | 3.09% |
| 1-year change | +3.94% | +50.09% | +69.27% | +58.00% | +21.80% | +16.90% |
| Today | +1.86% | +1.85% | +3.25% | +3.49% | +2.28% | +2.29% |
The closest companies by business and industry (Drug Manufacturers - General). Prices may be delayed up to 20 min.
Latest news
All AZN.ST news ›AstraZeneca and Oracle strike AI collaboration to speed up clinical trials
AstraZeneca and Oracle strike AI collaboration (AZN:NYSE) Seeking Alpha - AstraZeneca (AZN) on Tuesday announced a collaboration with Oracle (ORCL) to accelerate and optimize clinical studies by combining its scientific, R&D, and…
AstraZeneca partners with Oracle for AI-driven clinical trials
AstraZeneca and Oracle launch AI-powered real-world data trials in Abu Dhabi, accelerating recruitment and safety monitoring across multiple diseases AstraZeneca partners with Oracle for AI-driven clinical trials AstraZeneca and Oracle…
AstraZeneca, Oracle to launch their first global AI program in Abu Dhabi: CEO
CNBC AstraZeneca, Oracle to launch their first global AI program in Abu Dhabi: CEO
AstraZeneca Pharma set to move its registered office to Maharashtra, from Karnataka
The relocation of corporate office and employees marked the next phase of growth for the company through expanding access to innovation and deepening partnerships. Multinational drugmaker AstraZeneca Pharma India is set to move its…
Oracle, AstraZeneca Explore AI To Tackle Clinical-Trial Recruitment Challenge
Oracle (ORCL) shares were in focus on Tuesday after the company announced an agreement with AstraZeneca (AZN) to explore how artificial intelligence (AI) and real-world data could help clinicians identify eligible patients for clinical…
AstraZeneca works with Oracle to speed up drug trials
AstraZeneca is working with Oracle to investigate the use of artificial intelligence (AI) and real-world data to help identify eligible patients for clinical trials. The two companies also plan to accelerate evidence generation, and bring…
Amgen, AstraZeneca's Tezspire achieves 69% remission in Phase III EoE trial
AllSci is an AI-grounded scientific knowledge platform. It aggregates the global scientific literature, patents, grants and trials, atomizes them into hypotheses, questions, results and claims, links everything to canonical entity…
Oracle, AstraZeneca team up on AI innovation
Breakingthenews.net
AstraZeneca and Oracle team up on AI to find patients for drug trials
The first project targets uncontrolled high blood pressure in Abu Dhabi, with UAE healthcare company M42. AstraZeneca and Oracle will use AI and real patient health data to find people for drug trials faster, the two firms announced. The…
Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation
Oracle today announced an agreement with AstraZeneca to explore how AI and real-world data can help clinicians identify eligible patients for clinical trials, accelerate evidence generation, and bring relevant research insights into…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketscreener.com43
-
tradingview.com17
-
themarketsdaily.com7
-
biospace.com6
-
defenseworld.net5
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.